Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 965

1.

Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group.

Dellinger RP, Zimmerman JL, Taylor RW, Straube RC, Hauser DL, Criner GJ, Davis K Jr, Hyers TM, Papadakos P.

Crit Care Med. 1998 Jan;26(1):15-23.

PMID:
9428538
2.
3.

Acute and sustained effects of early administration of inhaled nitric oxide to children with acute respiratory distress syndrome.

Fioretto JR, de Moraes MA, Bonatto RC, Ricchetti SM, Carpi MF.

Pediatr Crit Care Med. 2004 Sep;5(5):469-74.

PMID:
15329164
4.

Inhaled nitric oxide in neonatal and pediatric acute respiratory distress syndrome: dose response, prolonged inhalation, and weaning.

Demirakça S, Dötsch J, Knothe C, Magsaam J, Reiter HL, Bauer J, Kuehl PG.

Crit Care Med. 1996 Nov;24(11):1913-9.

PMID:
8917045
5.

Acute oxygenation response to inhaled nitric oxide when combined with high-frequency oscillatory ventilation in adults with acute respiratory distress syndrome.

Mehta S, MacDonald R, Hallett DC, Lapinsky SE, Aubin M, Stewart TE.

Crit Care Med. 2003 Feb;31(2):383-9.

PMID:
12576940
6.

Inhaled nitric oxide does not enhance lipid peroxidation in patients with acute respiratory distress syndrome.

Weigand MA, Snyder-Ramos SA, Möllers AG, Bauer J, Hansen D, Kochen W, Martin E, Motsch J.

Crit Care Med. 2000 Oct;28(10):3429-35.

PMID:
11057797
7.

Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Enteral Nutrition in ARDS Study Group.

Gadek JE, DeMichele SJ, Karlstad MD, Pacht ER, Donahoe M, Albertson TE, Van Hoozen C, Wennberg AK, Nelson JL, Noursalehi M.

Crit Care Med. 1999 Aug;27(8):1409-20.

PMID:
10470743
8.

Dose-response curves of inhaled nitric oxide with and without intravenous almitrine in nitric oxide-responding patients with acute respiratory distress syndrome.

Lu Q, Mourgeon E, Law-Koune JD, Roche S, Vézinet C, Abdennour L, Vicaut E, Puybasset L, Diaby M, Coriat P, et al.

Anesthesiology. 1995 Nov;83(5):929-43.

PMID:
7486178
9.
10.

Inhaled nitric oxide in acute respiratory distress syndrome.

Johannigman JA, Davis K Jr, Campbell RS, Luchette F, Hurst JM, Branson RD.

J Trauma. 1997 Dec;43(6):904-9; discussion 909-10.

PMID:
9420103
11.

Low-dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial.

Taylor RW, Zimmerman JL, Dellinger RP, Straube RC, Criner GJ, Davis K Jr, Kelly KM, Smith TC, Small RJ; Inhaled Nitric Oxide in ARDS Study Group.

JAMA. 2004 Apr 7;291(13):1603-9.

PMID:
15069048
12.
14.

A multi-centre, double-blind, placebo-controlled study of liposomal prostaglandin E1 (TLC C-53) in patients with acute respiratory distress syndrome.

Vincent JL, Brase R, Santman F, Suter PM, McLuckie A, Dhainaut JF, Park Y, Karmel J.

Intensive Care Med. 2001 Oct;27(10):1578-83.

PMID:
11685297
15.

Treatment with N-acetylcysteine during acute respiratory distress syndrome: a randomized, double-blind, placebo-controlled clinical study.

Domenighetti G, Suter PM, Schaller MD, Ritz R, Perret C.

J Crit Care. 1997 Dec;12(4):177-82.

PMID:
9459113
16.

Neutrophil elastase inhibition in acute lung injury: results of the STRIVE study.

Zeiher BG, Artigas A, Vincent JL, Dmitrienko A, Jackson K, Thompson BT, Bernard G; STRIVE Study Group.

Crit Care Med. 2004 Aug;32(8):1695-702.

PMID:
15286546
17.

Prone positioning and inhaled nitric oxide: synergistic therapies for acute respiratory distress syndrome.

Johannigman JA, Davis K Jr, Miller SL, Campbell RS, Luchette FA, Frame SB, Branson RD.

J Trauma. 2001 Apr;50(4):589-95; discussion 595-6.

PMID:
11318005
18.

Inhaled nitric oxide variably improves oxygenation and pulmonary hypertension in patients with acute respiratory distress syndrome.

McIntyre RC Jr, Moore FA, Moore EE, Piedalue F, Haenel JS, Fullerton DA.

J Trauma. 1995 Sep;39(3):418-25.

PMID:
7473902
19.

Healthcare costs and long-term outcomes after acute respiratory distress syndrome: A phase III trial of inhaled nitric oxide.

Angus DC, Clermont G, Linde-Zwirble WT, Musthafa AA, Dremsizov TT, Lidicker J, Lave JR; NO-06 Investigators.

Crit Care Med. 2006 Dec;34(12):2883-90.

PMID:
17075373
20.

Dose-response characteristics during long-term inhalation of nitric oxide in patients with severe acute respiratory distress syndrome: a prospective, randomized, controlled study.

Gerlach H, Keh D, Semmerow A, Busch T, Lewandowski K, Pappert DM, Rossaint R, Falke KJ.

Am J Respir Crit Care Med. 2003 Apr 1;167(7):1008-15.

PMID:
12663340

Supplemental Content

Support Center